TP53 and cancer: Nevertheless, it is likely that EZH2 has an INK4a/ARF-independent function in cancer, because in mammary epithelial cells in which Rb and TP53 had been inactivated, ectopic expression of EZH2 contributed to anchorage-independent growth and invasion [3].